NON-DISCLOSURE AND CONFIDENTIALITY AGREEMENT

This Non-Disclosure and Confidentiality Agreement ("Agreement") is entered into as of the date of electronic execution set forth below, between GlobalX Solutions LLC, a Wyoming Limited Liability Company doing business as MyLooksLab ("Company"), with its principal place of business in Newport Beach, California, Managing Member: Matthew McCoy (matt@raisex.com), and the individual or entity executing this Agreement electronically below ("Recipient").

SECTION 1 — DEFINITION OF CONFIDENTIAL INFORMATION

1.1 "Confidential Information" means any and all information disclosed by the Company to Recipient in connection with the Company's private placement offering under Regulation D, Rule 506(b) of the Securities Act of 1933, including without limitation:

1. Financial statements, projections, models, and revenue data;
2. Business plans, strategies, and product roadmaps;
3. Technology architecture, AI development plans, and intellectual property;
4. Subscriber data, customer relationships, and growth metrics;
5. The existence, terms, or status of the offering;
6. Investor lists, term sheets, and SAFE note terms;
7. Any other information marked as confidential or that a reasonable person would understand to be confidential given its nature.

1.2 Confidential Information does not include information that: (a) is or becomes publicly known through no breach of this Agreement; (b) Recipient can demonstrate was rightfully known prior to disclosure; or (c) is independently developed without use of or reference to the Confidential Information.

SECTION 2 — OBLIGATIONS OF RECIPIENT

2.1 Non-Disclosure. Recipient agrees to hold all Confidential Information in strict confidence and not to disclose any Confidential Information to any third party without the prior written consent of the Company's Managing Member.

2.2 Non-Use. Recipient agrees to use the Confidential Information solely for the purpose of evaluating a potential investment in the Company and for no other purpose whatsoever.

2.3 Protection. Recipient agrees to protect the Confidential Information with at least the same degree of care it uses to protect its own confidential information, but in no event less than reasonable care.

2.4 No Reproduction. Recipient agrees not to copy, reproduce, download, screen-capture, or otherwise replicate any Confidential Information without prior written consent.

2.5 Personnel. Recipient agrees to limit disclosure of Confidential Information to those of its professional advisors (attorneys, CPAs) who: (a) have a need to know; and (b) are bound by confidentiality obligations at least as protective as this Agreement.

SECTION 3 — SECURITIES LAW COMPLIANCE

3.1 Recipient acknowledges that this offering is being made pursuant to Regulation D, Rule 506(b) of the Securities Act of 1933, as amended, and that the securities have not been registered with the Securities and Exchange Commission.

3.2 Recipient acknowledges that it is either an "accredited investor" as defined in Rule 501(a) of Regulation D, or a sophisticated investor with sufficient knowledge and experience in financial matters to evaluate the merits and risks of this investment.

3.3 Recipient agrees not to reproduce, distribute, publish, or forward this investor presentation to any third party without the prior written approval of the Company's Managing Member.

3.4 Recipient understands that this document does not constitute an offer to sell or a solicitation of an offer to buy any security, and that any investment decision must be made based upon, and in reliance solely upon, the final definitive documents provided by the Company.

SECTION 4 — INVESTMENT RISKS

4.1 Recipient acknowledges that investing in early-stage companies involves a high degree of risk, including the potential loss of the entire investment. Past performance and financial projections are not guarantees of future results.

4.2 Recipient has had the opportunity to consult with legal, tax, and financial advisors prior to executing this Agreement.

SECTION 5 — TERM AND TERMINATION

5.1 This Agreement shall remain in effect for a period of five (5) years from the date of execution, or until the Confidential Information becomes publicly known through no fault of Recipient, whichever occurs first.

5.2 Upon request by the Company, Recipient shall promptly return or destroy all Confidential Information and certify such destruction in writing.

SECTION 6 — REMEDIES

Recipient acknowledges that any breach of this Agreement may cause irreparable harm to the Company for which monetary damages would be inadequate, and that the Company shall be entitled to seek injunctive relief, specific performance, and any other remedies available at law or in equity.

SECTION 7 — GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of Wyoming, without regard to its conflict of law principles. Any dispute arising hereunder shall be resolved by binding arbitration in Orange County, California, administered by the American Arbitration Association.

SECTION 8 — ELECTRONIC SIGNATURE

The parties agree that an electronic signature shall be deemed a legal and binding signature for all purposes and shall have the same legal effect, validity, and enforceability as a handwritten signature under applicable law, including the Electronic Signatures in Global and National Commerce Act (E-SIGN Act) and the Uniform Electronic Transactions Act (UETA).

SECTION 9 — ENTIRE AGREEMENT

This Agreement constitutes the entire agreement between the parties with respect to its subject matter and supersedes all prior discussions, representations, or agreements. This Agreement may only be amended by a written instrument signed by both parties.

COMPANY: GlobalX Solutions LLC d/b/a MyLooksLab · Wyoming Limited Liability Company · Managing Member: Matthew McCoy · matt@raisex.com · Newport Beach, CA